Insights

Gathering insights about Inari…

Similar companies to Inari

Inari Tech Stack

Inari uses 8 technology products and services including Docker, Vue.js, QGIS, and more. Explore Inari's tech stack below.

Docker
Containerization
Vue.js
Javascript Frameworks
QGIS
Mapping And Gis
Cisco
Network Hardware
Python
Programming Languages
C++
Programming Languages
Yoast SEO
Search Engines
Meltwater
Social Media Analytics And Monitoring

Media & News

If You Could Only Hold 3 Investments for Life, Consider These
Warren Buffett, who is known to own “forever stocks,” has famously quipped that if you aren't willing to own a stock for 10 years, you shouldn't own it for even 10 minutes.
Mar 10, 2025 | www.marketbeat.com
Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment
Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: NARI), a company that provides innovative solutions for venous thromboembolism (VTE) clot removal without the use of thrombolytic drugs. The addition of Inari brings an established peripheral vascular position to Stryker in the fast-growing VTE segment.
Feb 19, 2025 | www.globenewswire.com
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.
Feb 14, 2025 | www.accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.
Feb 13, 2025 | www.accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out
NEW YORK CITY, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.
Feb 12, 2025 | www.accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Shareholders to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.
Feb 11, 2025 | www.accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.
Feb 10, 2025 | www.accessnewswire.com

Inari's Email Address Formats

Inari uses at least 1 format(s):

Inari Email Formats	Example	Percentage
FLast@inari.com	JDoe@inari.com	67%
Last@inari.com	Doe@inari.com	21%
First.Last@inari.com	John.Doe@inari.com	8%
First@inari.com	John@inari.com	4%

Frequently Asked Questions

Where is Inari's headquarters located?

Inari's main headquarters is located at Cambridge, Massachusetts 02139 United States. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Inari's stock symbol?

Inari is a publicly traded company; the company's stock symbol is NARI.

What is Inari's official website and social media links?

Inari's official website is inari.com and has social profiles on LinkedIn Crunchbase.

What is Inari's SIC code NAICS code?

Inari's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inari have currently?

As of April 2026, Inari has approximately 561 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: L. N. S.Ceo: M. B.Chief Commercial Officer (cco): R. D.. Explore Inari's employee directory with LeadIQ.

What industry does Inari belong to?

Inari operates in the Biotechnology Research industry.

What technology does Inari use?

Inari's tech stack includes DockerVue.jsQGISCiscoPythonC++Yoast SEOMeltwater.

What is Inari's email format?

Inari's email format typically follows the pattern of FLast@inari.com. Find more Inari email formats with LeadIQ.

How much funding has Inari raised to date?

As of April 2026, Inari has raised $144M in funding. The last funding round occurred on Jan 07, 2025 for $144M.

When was Inari founded?

Inari was founded in 2016.

Inari

Q: What is Inari's official website and social media links?

Inari's official website is inari.com. Inari has social profiles on LinkedIn.

Q: How many employees does Inari have currently?

Inari has approximately 561 employees.

Q: What technology does Inari use?

Inari's tech stack includes Apache Airflow, TeamViewer, Kotlin, Meltwater, Apache.

Q: What is Inari's NAICS code?

Inari's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchMassachusetts, United States501-1000 Employees

Inari is the SEEDesign™ company, using new breeding technology to push the boundaries of what is possible by designing nature-positive seeds for a more sustainable food system. A combination of AI-enabled predictive design and a cutting-edge multiplex gene editing toolbox enables Inari to unlock the full potential of seed and advance critical solutions with broad applications for growing more food with fewer resources – providing real benefits to farmers, our planet and the global population.

Company Overview

Headquarters: Cambridge, Massachusetts 02139 United States
Website: inari.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: NARI
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2016
Employees: 501-1000

Media & News

Funding & Financials

$144M
Inari has raised a total of $144M of funding over 8 rounds. Their latest funding round was raised on Jan 07, 2025 in the amount of $144M.

Funding & Financials

$144M
Inari has raised a total of $144M of funding over 8 rounds. Their latest funding round was raised on Jan 07, 2025 in the amount of $144M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Inari

Agriculture Capital

Corteva Agriscience

UNFOLD

Pivot Bio

AgBiome

Benson Hill

Pairwise

Syngenta

Inari Tech Stack

Media & News

If You Could Only Hold 3 Investments for Life, Consider These

Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation

Inari's Email Address Formats

Frequently Asked Questions

Where is Inari's headquarters located?

What is Inari's stock symbol?

What is Inari's official website and social media links?

What is Inari's SIC code NAICS code?

How many employees does Inari have currently?

What industry does Inari belong to?

What technology does Inari use?

What is Inari's email format?

How much funding has Inari raised to date?

When was Inari founded?

Inari

Company Overview

Media & News

If You Could Only Hold 3 Investments for Life, Consider These

Stryker completes acquisition of Inari Medical, Inc., providing entry into the high-growth peripheral vascular segment

Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?